List of Figures
Figure 1: Multiple Myeloma Therapeutics Market, Australia, Age-Specific Incidence Rate and Average Number of Cases, 2007–2011 15
Figure 2: Multiple Myeloma Therapeutics Market, Treatment Algorithm for Myeloma 20
Figure 3: Multiple Myeloma Therapeutics Market, Global, Heat Map for Initial Treatment – Efficacy 37
Figure 4: Multiple Myeloma Therapeutics Market, Global, Heat Map for Initial Treatment – Safety 38
Figure 5: Multiple Myeloma Therapeutics Market, Global, Heat Map for Maintenance Treatment 38
Figure 6: Multiple Myeloma Therapeutics Market, Global, Heat Map for Relapsed or Refractory Multiple Myeloma – Efficacy 38
Figure 7: Multiple Myeloma Therapeutics Market, Global, Heat Map for Relapsed or Refractory Multiple Myeloma – Safety 39
Figure 8: Multiple Myeloma Therapeutics Market, Global, Overview of Pipeline Products 41
Figure 9: Multiple Myeloma Therapeutics Market, Global, Target Families in Pipeline 44
Figure 10: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Overall Attrition Rate and Failure Rate by Phase (%), 2006–2015 45
Figure 11: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Overall Attrition Rate and Failure Rate by Phase and Molecule Type (%), 2006–2015 46
Figure 12: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Attrition Rate and Failure Rate by Phase and Molecular Target (%), 2006–2015 47
Figure 13: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Size per Product by Molecule Type (participants), 2006–2015 48
Figure 14: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Size per Individual Trial by Molecule Type (participants), 2006–2015 49
Figure 15: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Size per Product by Molecular Target (participants), 2006–2015 51
Figure 16: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Size per Individual Trial by Molecular Target (participants), 2006–2015 52
Figure 17: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2006–2015 54
Figure 18: Multiple Myeloma Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2006–2015 56
Figure 19: Multiple Myeloma Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 57
Figure 20: Multiple Myeloma Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 58
Figure 21: Multiple Myeloma Therapeutics Market, Global, Pipeline Heat Map, 2015 65
Figure 22: Multiple Myeloma Therapeutics Market, Asia-Pacific, Treatment Patterns (‘000) and Market Size ($bn), 2014–2021 68
Figure 23: Multiple Myeloma Therapeutics Market, India, Treatment Patterns (‘000), 2014–2021 69
Figure 24: Multiple Myeloma Therapeutics Market, India, Annual Cost of Therapy ($), 2014–2021 70
Figure 25: Multiple Myeloma Therapeutics Market, India, Market Size ($m), 2014–2021 71
Figure 26: Multiple Myeloma Therapeutics Market, China, Treatment Patterns (‘000), 2014–2021 72
Figure 27: Multiple Myeloma Therapeutics Market, China, Annual Cost of Therapy ($), 2014–2021 72
Figure 28: Multiple Myeloma Therapeutics Market, China, Market Size ($m), 2014–2021 73
Figure 29: Multiple Myeloma Market, Australia, Treatment Usage Patterns (‘000), 2014–2021 74
Figure 30: Multiple Myeloma Market, Australia, Annual Cost of Therapy ($), 2014–2021 74
Figure 31: Multiple Myeloma Therapeutics Market, Australia, Market Size ($m), 2014–2021 75
Figure 32: Multiple Myeloma Market, Japan, Treatment Usage Patterns (‘000), 2014–2021 76
Figure 33: Multiple Myeloma Market, Japan, Annual Cost of Therapy ($), 2014–2021 77
Figure 34: Multiple Myeloma Therapeutics Market, Japan, Market Size ($m), 2014–2021 78
Figure 35: Multiple Myeloma Therapeutics Market, Global, Licensing Deals by Region, 2006–2015 81
Figure 36: Multiple Myeloma Therapeutics Market, Global, Licensing Deals by Deal Value ($m), 2006–2015 82
Figure 37: Multiple Myeloma Therapeutics Market, Global, Number of Deals and Aggregate Deal Value ($m), 2006–2015 83
Figure 38: Multiple Myeloma Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value ($m) and Upfront Payment Value ($m), 2006–2015 84
Figure 39: Multiple Myeloma Therapeutics Market, Global, Licensing Deals by Molecule Type, Stage of Development and Aggregate Deal Value ($m), 2006–2015 85
Figure 40: Multiple Myeloma Therapeutics Market, Global, Licensing Deals by Molecular Target, 2006–2015 87
Figure 41: Multiple Myeloma Therapeutics Market, Global, Co-development Deals by Region, 2006–2015 89
Figure 42: Multiple Myeloma Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, 2006–2015 90
Figure 43: Multiple Myeloma Therapeutics Market, Global, Co-development Deals by Stage of Development, 2006–2015 91
Figure 44: Multiple Myeloma Therapeutics Market, Global, Co-development Deals by Molecule Type and Stage of Development, 2006–2015 92
Figure 45: Multiple Myeloma Therapeutics Market, Global, Co-development Deals by Molecular Target, 2006–2015 93